Breast Care A-Z · Concept · MICROCALC

Microcalcifications

also: calcifications, breast calcifications, calcification cluster, microcalcs · pronounced my-kroh-kal-si-fi-KAY-shuns

Microcalcifications are tiny specks of calcium in the breast that show up on a mammogram; most are harmless, but certain patterns can be an early sign of DCIS and need further checks. You may have been told your mammogram shows them, or that some need investigation — the word can sound alarming when first heard.

Quick answers

Are calcifications a sign of cancer?

Most calcifications are not. The vast majority of calcifications seen on mammograms are benign. Some patterns — particularly grouped, linear, or branching microcalcifications with fine pleomorphic or casting morphology — are concerning and warrant a biopsy. The radiologist's assessment of the pattern is what matters, not the presence of calcifications alone.

Can calcifications go away on their own?

No — calcium deposits in breast tissue are permanent. They can sometimes change appearance subtly over time, but they do not disappear. Reassuringly, this means that benign calcifications, once classified, can be confidently watched on follow-up imaging without repeated biopsies.

Can I cause calcifications by drinking calcium?

No. Calcifications in the breast are not caused by dietary calcium and are not affected by calcium intake or supplements. They are a localised tissue process and are unrelated to systemic calcium balance.

PLATE XLIX · RADIOLOGY · MAMMOGRAPHIC FINDINGS microcalcifications mammographic calcifications · calcific deposits calcium deposits within breast tissue visible on mammography, ranging from definitively benign to highly suspicious for malignancy FIG 01–07 · MICROCALCIFICATIONS · XLIX FIG 01 · MAMMOGRAPHIC APPEARANCE DIAGRAM Benign pattern (scattered round) Suspicious cluster (fine pleomorphic) i · scattered round calcifications (benign) ii · pleomorphic cluster (suspicious) iii · linear / branching (casting) iv · segmental distribution pattern v · associated architectural distortion UK R-CATEGORY / ACR BI-RADS DESCRIPTORS Morphology — Typically Benign: Round · Rim · Coarse / popcorn Morphology — Suspicious: Amorphous · Fine pleomorphic Fine linear / branching Distribution: Diffuse · Regional · Grouped · Linear · Segmental ACR BI-RADS Atlas 5th edition MANAGEMENT PATHWAY M1–M2 (BI-RADS 1–2) Benign morphology → Routine recall M3 (BI-RADS 3) Probably benign → 6-month follow-up M4–M5 (BI-RADS 4–5) Suspicious → Stereotactic core biopsy Per NICE NG12 / ACR guidelines FIG 02 · BENIGN vs MALIGNANT-TYPE CALCIFICATIONS Feature Benign Morphology Malignant-type Morphology Round, oval, rim, coarse Fine pleomorphic, linear Distribution Diffuse, bilateral, scattered Segmental, linear, clustered Size Coarse (>0.5 mm) Fine (<0.5 mm) Number Variable Grouped cluster ≥5 BI-RADS 1 or 2 4 or 5 Associated mass Absent May be present Change over time Stable New or increasing Typical cause Fibroadenoma, vascular, cyst DCIS, comedo necrosis Biopsy Not indicated Stereotactic biopsy Significance Benign, reassuring Requires histological assessment FIG 03 · ACR MORPHOLOGY CATEGORIES Morphology Significance Action Skin calcifications Benign (dermal) No action Vascular calcifications Benign (vessel wall) No action Coarse / popcorn Benign (fibroadenoma) No action Round / punctate Usually benign BI-RADS 2 or 3 Amorphous Low suspicion BI-RADS 3–4A Coarse heterogeneous Intermediate suspicion BI-RADS 3–4B Fine pleomorphic Higher suspicion BI-RADS 4B–4C Fine linear / branching High suspicion (DCIS) BI-RADS 4C–5 Milk of calcium Benign (cyst) BI-RADS 2 FIG 04 · DIAGNOSTIC PIPELINE 1 Screening mammogram step 1 2 Calcifications detected step 2 3 BI-RADS categorisation step 3 4 Recall if BI-RADS ≥3 step 4 5 Stereotactic core biopsy step 5 6 Histology + MDT step 6 FIG 05 · CALCIFICATION TYPES Popcorn (fibroadenoma) Eggshell / rim (cyst) Milk of calcium Fine pleomorphic cluster Linear / branching (casting) Comedo-type DCIS FIG 06 · KEY STATISTICS ~50% screen-detected DCIS presents as calcifications [1] 5% recall rate for calcifications on screening [2] ~25% M4 (BI-RADS 4) PPV for malignancy [3] >85% M5 (BI-RADS 5) PPV for malignancy [3] FIG 07 · REFERENCES 1. Holland R et al. DCIS and calcifications. Semin Diagn Pathol 1994 2. NHS Breast Screening Programme. Annual review 2023 3. ACR BI-RADS Atlas 5th edition 2013 4. Rominger M et al. BI-RADS calcification PPV. Eur Radiol 2020 5. NICE NG12. Suspected cancer referral guidance 2023 Clinically authored by Dr Fiona Tsang-Wright , FRCS (Gen Surg) GMC 4549831 · ORCID 0000-0003-4801-026X
Visual Reference · Microcalcifications
Open full size ↗
Definition
Microcalcifications are tiny specks of calcium that show up on a mammogram as small white dots — most are benign and need no action, but specific patterns can indicate early breast cancer or DCIS and warrant further investigation.

Common questions The questions patients ask first

Are calcifications a sign of cancer?
Most calcifications are not. The vast majority of calcifications seen on mammograms are benign. Some patterns — particularly grouped, linear, or branching microcalcifications with fine pleomorphic or casting morphology — are concerning and warrant a biopsy24. The radiologist's assessment of the pattern is what matters, not the presence of calcifications alone.
Can calcifications go away on their own?
No — calcium deposits in breast tissue are permanent. They can sometimes change appearance subtly over time, but they do not disappear. Reassuringly, this means that benign calcifications, once classified, can be confidently watched on follow-up imaging without repeated biopsies.
Can I cause calcifications by drinking calcium?
No. Calcifications in the breast are not caused by dietary calcium and are not affected by calcium intake or supplements. They are a localised tissue process and are unrelated to systemic calcium balance.
Will I need surgery?
Surgery is needed only when the biopsy confirms a finding that warrants it — DCIS, invasive cancer, or certain atypical findings. The biopsy is the step that decides; the calcifications themselves do not necessitate surgery.

Microcalcifications are tiny specks of calcium that show up on a mammogram as small white dots — most are benign and need no action, but specific patterns can indicate early breast cancer or DCIS and warrant further investigation.

Calcifications are very common — most women have some, and most are entirely harmless. The radiologist looks at their pattern, distribution, and shape, not just their presence. Some patterns can be reassuringly classified as benign on imaging alone; others need a biopsy to confirm what is causing them. The most useful piece of information for any patient told they have calcifications is which category they fall into.

Orientation Why you might be reading about this

You may have been told that your mammogram shows microcalcifications, or that some calcifications need further investigation. The word can sound alarming when first heard. This page explains what calcifications are, what makes some patterns more concerning than others, and what the next steps are.

Related terms: Mammogram · DCIS · Core biopsy · Breast MRI

Definition What microcalcifications are

Calcifications are tiny deposits of calcium that form in breast tissue. They appear as small white dots on a mammogram — calcium absorbs X-rays strongly, so even tiny deposits show up clearly. They are categorised by size:

  • Macrocalcifications (larger than ~0.5 mm) — usually associated with benign processes such as ageing, previous trauma, or a benign cyst that has calcified. They are reassuring and almost never need investigation.
  • Microcalcifications (smaller than ~0.5 mm) — small deposits that need closer assessment. Most are still benign, but some patterns can indicate DCIS or early invasive cancer.

When a mammogram report mentions calcifications, the relevant question is what they look like — not whether they are present.

Categorisation How calcifications are categorised

Radiologists use a structured approach (the BI-RADS system in many UK and international centres) to classify what they see1. The categories run from “definitely benign” through “uncertain” to “highly suspicious”. The features that the radiologist considers include:

Distribution — how they are spread

  • Diffuse / scattered throughout the breast — usually benign.
  • Regional — clustered in a wider area — usually benign.
  • Grouped — clustered in a small area (less than 1 cm) — needs closer assessment.
  • Linear or branching — following the line of a duct — more often associated with DCIS.
  • Segmental — covering a wedge of breast in a duct distribution — also more concerning.

Morphology — what individual specks look like

  • Round, smooth — usually benign.
  • Punctate (small, dot-like) — often benign.
  • Coarse / heterogeneous (varied sizes, irregular) — uncertain; closer assessment needed.
  • Fine pleomorphic (very small, varied shapes) — more concerning.
  • Fine linear / branching (“casting” calcifications) — most concerning; commonly associated with DCIS.

A radiologist puts these features together and assigns an overall category1. The categories most likely to lead to further investigation are those with grouped, linear, or branching distribution combined with fine pleomorphic or casting morphology — empirically the descriptors with the highest positive predictive value for cancer24.

Workup What happens when calcifications need investigation

If the calcifications fall into a category that warrants tissue sampling, the standard next step is a stereotactic vacuum-assisted biopsy (VAB) — a needle biopsy performed under mammographic guidance that retrieves multiple larger tissue samples and confirms calcium has been sampled by specimen radiograph, with the breast positioned in a specialised biopsy machine3. This allows the needle to target the exact calcium deposit visible on the mammogram.

The biopsy result then shows what is causing the calcifications. Common findings:

  • Benign — the most common outcome. Causes include normal breast tissue ageing, fibrocystic change, sclerosing adenosis, or a benign papilloma.
  • DCIS — ductal carcinoma in situ, the most common cancer-related cause of suspicious calcifications. Calcifications are often the way DCIS is first detected.
  • Invasive cancer — less commonly, the calcifications are associated with an invasive ductal or invasive lobular cancer.
  • Atypical findings (atypical ductal hyperplasia, lobular neoplasia, radial scar) — benign but with raised future risk; often surgically excised to confirm there is no associated higher-risk change.

When DCIS or invasive cancer is found, the extent of the calcifications on imaging guides the surgical plan — particularly whether a lumpectomy is sufficient or whether mastectomy is the better operation5. Calcifications that extend over a wide area sometimes mean DCIS or cancer that is more extensive than would be suspected from clinical examination alone.

When calcifications need investigation, that work usually happens in a one-stop clinic. How imaging and biopsy sit together is described on the symptoms and assessment pages.

In follow-up Calcifications during follow-up

After breast cancer treatment, patients are followed with annual mammograms for several years, partly to look for new calcifications that could indicate recurrence. New calcifications in a previously treated breast are assessed in the same way as those in any breast — most turn out to be benign post-treatment changes (scar, fat necrosis from radiotherapy), but suspicious patterns warrant biopsy.

At consultation What to discuss at consultation

If your mammogram report mentions calcifications:

  • What category the calcifications fall into — benign, uncertain, or suspicious.
  • What the next step is — no action, follow-up imaging, or biopsy.
  • What the biopsy involves if one is recommended — usually stereotactic vacuum-assisted biopsy (VAB) under mammographic guidance.
  • What different biopsy outcomes might mean for the treatment pathway.

Resources Further reading

Sources & guidance

Every figure on this page is anchored to a published source. Tap a number in the text or below to jump to the reference.

  1. reference text American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI-RADS) Atlas, 5th edition — Mammography. Reston, VA: ACR. 2013 ;Chapter on calcifications: morphology and distribution descriptors https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Reporting-and-Data-Systems/BI-RADS Cited for: BI-RADS lexicon for calcifications: morphology (round, punctate, coarse heterogeneous, fine pleomorphic, fine linear/branching) and distribution (diffuse, regional, grouped, linear, segmental); category framework (BI-RADS 1–5).
  2. cohort Burnside ES, Ochsner JE, Fowler KJ, et al. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology. 2007 ;242(2):388–395 doi:10.1148/radiol.2422052130 Cited for: Positive predictive value of microcalcification morphology — fine linear/branching highest, round/punctate lowest; underpins biopsy thresholds.
  3. guidance Royal College of Radiologists / Public Health England / NHS Breast Screening Programme. Clinical guidance for breast cancer screening assessment (NHSBSP Publication 49). London: PHE / RCR. 2016 ;4th edition https://www.gov.uk/government/publications/breast-screening-clinical-guidelines-for-screening-management Cited for: UK pathway for the assessment of microcalcifications detected at screening, including stereotactic biopsy indications.
  4. cohort Bent CK, Bassett LW, D'Orsi CJ, Sayre JW. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. American Journal of Roentgenology. 2010 ;194(5):1378–1383 doi:10.2214/AJR.09.3423 Cited for: Empirical PPVs by BI-RADS calcification descriptor; supports decision to biopsy grouped/linear/segmental clusters with suspicious morphology.
  5. guideline National Institute for Health and Care Excellence (NICE). Early and locally advanced breast cancer: diagnosis and management (NG101). London: NICE. 2018 ;Last updated 2024 https://www.nice.org.uk/guidance/ng101 Cited for: Surgical planning when biopsy of microcalcifications confirms DCIS or invasive cancer; extent on imaging informs lumpectomy vs mastectomy decision.